Posts tagged “LabCorp”
Triangle headlines: Ex-Army Ranger's startup; Moogfest wants $$$; 8 TED lessons; LabCorp's investment
In a roundup of Triangle tech news as reported by other media outlets: An ex-Army Ranger is building a promising startup; Moogfest wants financial support from Durham; a recap of the recent TEDx event in Raleigh; and a Boston firm lands backing from LabCorp.
Quintiles is one of only four North Carolina companies that improved their standing in the 2015 Fortune 500 list. Quintiles also is one of only two N.C. life science firms to make the elite, just slightly below rival LabCorp.
Covance boosts LabCorp earnings; ESPN sues Verizon; data case to SCOTUS; Apple Pay for Discover; Raleigh startup raises $470,000
In today's Bulldog wrapup of life science and technology news: Covance gives a boost to LabCorp earnings but currency headwinds hurt; ESPN sues Verizon over unbundling; the Supreme Court to hear personal data privacy case; Discover supports Apple Pay; and a Raleigh photo app startup raises $470,000.
Leading health diagnostics firm Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH), is the first participant in BRCA Share, a novel datashare initiative to provide scientists and laboratory organizations around the world with open access to genetic data associated with cancer.
LabCorp's $6.2B deal; IBM targets EMC; DeSoto cab now Flywheel; Yahoo leyes apps for $$$; Samsung vs. Apple Pay
In today's Bulldog wrapup of technology and life science news: LabCorp's $6.2 billion deal for Covance closes; IBM's new flash storage targets EMC; DeSoto cab now Flywheel; Yahoo looks to mobile apps for cash; and Samsung targets Apple Pay with LoopPay deal.
Burlington-based Laboratory Corporation of America plans to buy Covance in a deal worth some $6.1 billion. The acquisition would form what LabCorp is calling "the world's largest healthcare diagnostics company."
LabCorp earnings decline; Centice makes big sale; Facebook advertising surges; old Apple brings top dollar; FTC picks privacy expert
In today's Bulldog wrapup of tech and life science news: LabCorp's revenue climbs but earnings decline; Centice in RTP makes big sale in drug abuse technology; Facebook's advertising soars; an old Apple sells for a lot of money; and the FTC's new top technologist is a privacy expert.
Red Hat-SAP mobile deal; Microsoft CEO earns $84M; LabCorp's new HIV test; NC falls to 3rd in biz climate; Honda Aircraft expands
In today's Bulldog wrapup of life science and technology news: Red Hat and SAP partner in the cloud; Microsoft's CEO earns $84 million pay package; LabCorp launches new HIV test; North Carolina slips in a business climate survey; and Honda Aircraft keeps growing in the Triad.
LabCorp-LipoScience deal advances; Red Hat's new women awards; a comet landing; eBay's miss; NetFlix plunge
In today's wrapup of tech and life science news: LabCorp's $85M acquisition of LipoScience clears a key hurdle; Red Hat announces women in Open Source awards; a comet landing is at hand; eBay's miss; and NetFlix stock plunges.
BD reboots startup program; NePhroGenex clinical trial; Red Hat Summit; OxyBio update; LabCorp board shuffle
In the latest Bulldog roundup of life science and technology news: BD Technologies re-launches incubator program; NePhroGenex reports a loss for 2013 but secures providers for big clinical trial; Red Hat adds IBM exec to Summit lineup; OxyBio can resume testing; and LabCorp shuffles board.
Google Glass goes for style; Box plans IPO; nCino, LabCorp name new execs; Disney makes YouTube play
The latest Bulldog roundup: Google Glass goes for fashion in deal with Ray-Ban, Oakley; web storage startup Box is going public; cloud banking firm nCino adds a VP for revenue and strategy; LabCorp hires a new CFO; and Disney is buying Maker Studios for $500 million.
LabCorp (NYSE:LH) processed more tests in the fourth quarter than it did same period in the prior year but it made less money per test and the laboratory testing and diagnostics firm's revenue and earnings results fell short of analyst estimates.
LabCorp is among the first laboratories offering NanoString Technologies' prognostic breast cancer test, which has been shown in studies to offer better information compared to existing cancer assays.
Myriad Genetics, the company that went all the way to the U.S. Supreme Court seeking patents on human genes, now claims LabCorp's new genetic tests for breast cancer infringe on its patents. Read more about the suit.
Garheng Kong, a former partner at venture capital firm Intersouth Partners in Durham, is the newest member of the board at lab testing giant LabCorp.